durapatite has been researched along with aspirin in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Bardow, A; Nauntofte, B; Nyvad, B | 1 |
| Abizaid, A; Bonan, R; Costa, JR; Costa, R; Feres, F; Mattos, LA; Siqueira, D; Sousa, AG; Sousa, JE; Staico, R; Tanajura, LF | 1 |
| Peters-Krabbendam, I; Serruys, PW; Sorop, O; van Beusekom, HM; van der Giessen, WJ | 1 |
| Abizaid, A; Bonan, R; Costa, JR; Costa, R; Feres, F; Maldonado, G; Siqueira, D; Sousa, AG; Sousa, JE; Staico, R; Tanajura, LF | 1 |
| Arkins, JP; Dayan, SH; Mathison, CC | 1 |
| Jayabalan, M; Komeri, R; Paul, W; Sharma, CP; Victor, SP; Vineeth, VM | 1 |
| Guo, H; He, J; Huang, F; Ji, M; Li, H; Li, S; Shen, Y; Wang, S; Xie, A | 1 |
| Li, Y; Lu, H; Ma, N; Tao, Z; Wu, X; Xu, HG; Yang, M; Zhang, R; Zhou, W | 1 |
8 other study(ies) available for durapatite and aspirin
| Article | Year |
|---|---|
Relationships between medication intake, complaints of dry mouth, salivary flow rate and composition, and the rate of tooth demineralization in situ.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Antidepressive Agents; Antihypertensive Agents; Aspirin; Buffers; Durapatite; Estrogens; Female; Humans; Hydrogen-Ion Concentration; Lactobacillus; Male; Middle Aged; Regression Analysis; Risk Assessment; Root Caries; Saliva; Salivary Proteins and Peptides; Secretory Rate; Statistics, Nonparametric; Tooth Demineralization; Xerostomia | 2001 |
Preliminary results of the hydroxyapatite nonpolymer-based sirolimus-eluting stent for the treatment of single de novo coronary lesions a first-in-human analysis of a third-generation drug-eluting stent system.
Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Cardiovascular Agents; Clopidogrel; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Thrombosis; Drug-Eluting Stents; Durapatite; Female; Humans; Male; Middle Aged; Pilot Projects; Platelet Aggregation Inhibitors; Prosthesis Design; Registries; Sirolimus; Stainless Steel; Ticlopidine; Time Factors; Treatment Outcome; Ultrasonography, Interventional | 2008 |
Lowering the dose of sirolimus, released from a nonpolymeric hydroxyapatite coated coronary stent, reduces signs of delayed healing.
Topics: Angioplasty, Balloon, Coronary; Animals; Aspirin; Cardiovascular Agents; Clopidogrel; Coated Materials, Biocompatible; Coronary Angiography; Coronary Restenosis; Coronary Vessels; Drug-Eluting Stents; Durapatite; Hyperplasia; Lipids; Materials Testing; Models, Animal; Platelet Aggregation Inhibitors; Prosthesis Design; Sirolimus; Stainless Steel; Surface Properties; Sus scrofa; Ticlopidine; Wound Healing | 2009 |
1-year results of the hydroxyapatite polymer-free sirolimus-eluting stent for the treatment of single de novo coronary lesions: the VESTASYNC I trial.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Durapatite; Female; Humans; Intensive Care Units; Male; Middle Aged; Platelet Aggregation Inhibitors; Polymers; Prospective Studies; Sirolimus; Ticlopidine; Time Factors; Ultrasonography | 2009 |
Management of impending necrosis associated with soft tissue filler injections.
Topics: Adult; Antacids; Aspirin; Cosmetic Techniques; Durapatite; Female; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Injections; Necrosis; Nitroglycerin; Oxygen | 2011 |
Neodymium doped hydroxyapatite theranostic nanoplatforms for colon specific drug delivery applications.
Topics: Animals; Aspirin; Colon; Drug Delivery Systems; Durapatite; Dynamic Light Scattering; Fibroblasts; HeLa Cells; Humans; Hydrogen-Ion Concentration; Mice; Neodymium; Organ Specificity; Particle Size; Spectrum Analysis, Raman; Static Electricity; Theranostic Nanomedicine | 2016 |
A novel porous aspirin-loaded (GO/CTS-HA)n nanocomposite films: Synthesis and multifunction for bone tissue engineering.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antipyretics; Aspirin; Cell Line; Cell Proliferation; Chitosan; Delayed-Action Preparations; Durapatite; Graphite; Mesenchymal Stem Cells; Mice; Nanocomposites; Oxides; Porosity; Tissue Engineering; Tissue Scaffolds | 2016 |
Local administration of aspirin improves osseointegration of hydroxyapatite-coated titanium implants in ovariectomized rats through activation of the Notch signaling pathway.
Topics: Animals; Aspirin; Coated Materials, Biocompatible; Drug Carriers; Drug Liberation; Durapatite; Female; Humans; Mechanical Phenomena; Osseointegration; Ovariectomy; Prostheses and Implants; Rats; Rats, Sprague-Dawley; Receptors, Notch; Signal Transduction; Titanium | 2020 |